The number of people living with brain diseases like Alzheimer’s disease and Parkinson’s disease is rising around the world. As populations age, doctors and scientists are working harder than ever to find ways to prevent or delay these serious conditions. This topic is now part of Latest News, Breaking News, and even regular Daily news highlights because it affects millions of families.
Now, a large study from South Korea has found something interesting: certain medicines used to treat type 2 diabetes may also lower the risk of developing dementia and Parkinson’s disease.
What the Study Found
Researchers from Yonsei University College of Medicine studied more than 350,000 people with type 2 diabetes. They wanted to see whether a group of diabetes drugs called SGLT2 inhibitors had any effect on brain health.
The results were surprising and hopeful:
- People taking SGLT2 inhibitors had a 21% lower risk of all types of dementia.
- The risk of Parkinson’s disease was 20% lower.
- The risk of Alzheimer’s disease was 19% lower.
- The risk of vascular dementia was 31% lower.
These findings were published in American Academy of Neurology’s journal Neurology.
The study followed participants for an average of about two to four years. All participants were over the age of 40.
What Are SGLT2 Inhibitors?
SGLT2 inhibitors are a type of medicine used to treat type 2 diabetes. They work by helping the body remove extra sugar through urine. This lowers blood sugar levels.
But these drugs do more than just control sugar:
- They reduce insulin levels.
- They increase ketone production in the body.
- They improve heart health.
Ketones are special chemicals that can act as an alternative energy source for the brain. Some scientists believe ketones may protect brain cells from damage.
Dr. Minyoung Lee, one of the researchers, explained that people with type 2 diabetes already have a higher risk of brain diseases. Diabetes can damage blood vessels and affect how the brain uses energy. So, finding a medicine that helps both diabetes and brain health could be very important.
Why Diabetes and Brain Disease Are Connected
There are strong links between type 2 diabetes and neurodegenerative diseases.
Here’s why:
- High blood sugar over time damages blood vessels.
- Insulin resistance affects how brain cells function.
- Obesity and high blood pressure increase dementia risk.
- Heart disease reduces healthy blood flow to the brain.
SGLT2 inhibitors help improve many of these risk factors. By lowering blood sugar and improving heart health, they may protect the brain from long-term damage.
Some experts believe the benefits are not just from sugar control, but from overall improvements in metabolism and blood circulation.
Younger Patients Saw Bigger Benefits
One of the most interesting parts of the study was age-related results.
People under 65 or 70 years old showed even greater benefits compared to older patients. This suggests that starting treatment earlier may provide stronger protection.
This finding supports the idea of early intervention. If doctors can reduce risk factors earlier in life, they may slow down or delay the start of dementia or Parkinson’s disease.
That does not mean these medicines completely prevent brain disease. Instead, they may delay the process.
Important Things to Remember
Although the results are promising, there are a few important points:
- The study was observational. That means it showed a link but did not prove direct cause and effect.
- More long-term research is needed.
- Scientists still need to fully understand how the drugs protect the brain.
Dr. Lee explained that she believes the medicine may slow down the disease process rather than completely stop it. On a population level, even delaying dementia by a few years could reduce the number of people affected worldwide.
That is why this research is receiving attention in Breaking News health reports and Daily news highlights across medical platforms.
Why This Matters Globally
Neurodegenerative diseases are growing worldwide because people are living longer. According to global health experts:
- Dementia cases are expected to rise sharply in the coming decades.
- Parkinson’s disease rates are also increasing.
- There is still no complete cure for either condition.
If a common diabetes drug can reduce risk by around 20%, that could have a huge public health impact.
Type 2 diabetes itself is also increasing globally. This means millions of people are already taking medications like SGLT2 inhibitors. If these medicines offer extra brain protection, that could be a major added benefit.
What Happens Next?
Researchers plan to continue studying how these medicines affect brain cells. Some are using animal models to better understand the biological process.
Future studies may focus on:
- Longer follow-up periods.
- Testing in non-diabetic populations.
- Understanding the exact brain mechanisms involved.
If future research confirms these findings, doctors may start thinking differently about diabetes treatment—not just for blood sugar control, but also for long-term brain health.
